Litcius/Paper detail

Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension

Anne F. Luetkemeyer, Deborah Donnell, Stephanie E. Cohen, Julia C. Dombrowski, Cole Grabow, Grace C. Haser, Clare Brown, Chase A. Cannon, Cheryl Malinski, Rodney Perkins, Melody Nasser, Carolina B. López, Robert J. Suchland, Eric Vittinghoff, Susan Buchbinder, Hyman Scott, Edwin D. Charlebois, Diane V. Havlir, Olusegun O. Soge, Connie Celum

2025The Lancet Infectious Diseases38 citationsDOI

Topics & Concepts

Open labelDoxycyclineMedicineInternal medicineRandomized controlled trialAntibioticsMicrobiologyBiologyReproductive tract infections researchSyphilis Diagnosis and TreatmentAdolescent Sexual and Reproductive Health
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension | Litcius